Cited by 903Cardiovascular Function and Risk FactorsCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.

Molecular mechanisms of diabetic cardiomyopathy

Open access

Bugger, Heiko, Abel, E. Dale·2014·Diabetologia

DOI 10.1007/s00125-014-3171-6PMC PMC3969857

Open this paper in CoChat — free account Open PDF

Abstract

In recent years, diabetes mellitus has become an epidemic and now represents one of the most prevalent disorders. Cardiovascular complications are the major cause of mortality and morbidity in diabetic patients. While ischaemic events dominate the cardiac complications of diabetes, it is widely recognised that the risk for developing heart failure is also increased in the absence of overt myocardial ischaemia and hypertension or is accelerated in the presence of these comorbidities. These diabetes-associated changes in myocardial structure and function have been called diabetic cardiomyopathy. Numerous molecular mechanisms have been proposed to contribute to the development of diabetic cardiomyopathy following analysis of various animal models of type 1 or type 2 diabetes and in genetically modified mouse models. The steady increase in reports presenting novel mechanistic data on this subject expands the list of potential underlying mechanisms. The current review provides an update on molecular alterations that may contribute to the structural and functional alterations in the diabetic heart.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3171-6

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts
Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., Zhang, Y., Yang, B., & Wang, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700015200 · Cited by 233
Retracted
Retracted: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy
Ma, H., Li, S., Xu, P., Babcock, S. A., Dolence, E. K., Brownlee, M., Li, J., & Ren, J. T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00547.x · Cited by 154
Retracted
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
The Framingham Study
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520

Show all 153 references

Sorted by citations

Items 801–900 of 903

Molecular description of fibroblast growth factor and mechanisms by which fibroblast growth factor-21 mediating biological actions and acting as a biologic biomarker of cardiovascular diseases
Melaku, L. S., & Debela, N. (2020) · Indian Journal of Health Sciences and Biomedical Research (KLEU) · doi:10.4103/kleuhsj.kleuhsj_92_20
Mesa 2: Insuficiencia cardíaca y diabetes mellitus tipo 2
Méndez, J., Martín, C. G., Remón, J., Houssay, S., Forte, E. H., Manfredo, S., Roselli, M., Ré, M., Hernández, D., Margossian, M., et al. (2020) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v54i2sup.252
Comprehensive Analysis of Differentially Expressed Profiles of circRNAs in Diabetic CardiomyopathyPreprint
Wu, Y., Cheng, N., Zhang, Y., Li, L., Mao, L., & Wang, R. (2020) · doi:10.21203/rs.3.rs-37480/v1
The Effects of Ginsenoside Rb1 on Cardiac Structure, Function and Myocardial Fibrosis in Diabetes Rats
李, 泽. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.112071
Gestational Diabetes Mellitus Induces Neuroinflammation, Synaptic Reduction, Behavioural Changes, and Impaired Memory in the Offspring.
Vuong, B. (2016) · Mspace (University of Manitoba)
Emerging diagnostic and predictive utilities of natriuretic peptides in diabetes mellitus patients at high cardiovascular risk
Berezin, A. Е., & Berezin, A. A. (2020) · Integrative Molecular Medicine · doi:10.15761/imm.1000393
Peer Review #2 of "Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease? (v0.1)"
(2021) · PeerJ · doi:10.7287/peerj.11485v0.1/reviews/2
Peer Review #2 of "Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease? (v0.2)"
(2021) · PeerJ · doi:10.7287/peerj.11485v0.2/reviews/2
El losartán disminuye la expresión del receptor para compuestos de glicosilación avanzada en el tejido cardiaco de ratas diabéticas
Pedreáñez, A. B., Muñóz, N., & Mosquera, J. (2021) · Revista Ecuatoriana de Medicina y Ciencias Biológicas · doi:10.26807/remcb.v42i1.883
Features of Pathogenesis and Course of Type 2 Diabetes Mellitus and Comorbid with it Cardiovascular Pathology in Elderly Patients
Gorb, Y. G., Strona, V. I., Ev, T., Serik, S. A., & Ryabukha, V. V. (2021) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs06.03.022 · Cited by 2
GDF11 Mitigates Diabetic Cardiomyopathy Injury Via Regulation of the ALKBH5-FOXO3-CDR1as/Hippo PathwayPreprint
Shao, Y., Li, M., Yu, Q., Gong, M., Wang, Y., Yang, X., Liu, L., Liu, D., Tan, Z., Zhang, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3864033
The Effect of Resistance Exercise on Myocardial Inflammatory Cytokines and ERK1/2 Expression in Type 2 Diabetic Rats
Kim, M.-J., Kim, K.-L., & An, M.-J. (2021) · Exercise Science · doi:10.15857/ksep.2021.30.3.309
Possibilities of predicting preclinical forms of cardiovascular diseases in young patients with type 1 diabetes mellitus using cardiac magnetic resonance imaging
Андреевич, П. К., Bondarenko, I. Z., Biryukova, E. V., Shatskaya, O. A., Tarbaeva, N. V., Vorontsov, А. V., & Shestakova, M. V. (2021) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2021-36-3-51-58
Hub Targets Analysis of miRNA-mRNA-TF Network in Diabetic CardiomyopathyPreprint
Ren, B., He, K., Yuan, M., Wang, Y., Tie, Y., & Gao, D. (2021) · Research Square · doi:10.21203/rs.3.rs-1013451/v1
Cardioprotector effect of Phosphodiesterase 5 inhibitors in experimental model for Diabetes Mellitus
Freitas, G. N., & Silva, C. D. O. (2021) · ABCS Health Sciences · doi:10.7322/abcshs.2019164.1433
Competitive strategy for an Indian natural stone trader
van Poppelen, M. (2009)
Imaging Myocardial Metabolism
Gropler, R. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00083-1
Role of CK1ε-regulated PERIOD2 in STZ-induced diabetic myocardial injury
Huang, Q., Jiang, M., Xia, Z., Lei, S., Zhao, B., & Qiu, Z. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2702058
Peer Review #1 of "Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease? (v0.1)"
(2021) · PeerJ · doi:10.7287/peerj.11485v0.1/reviews/1
Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes and Protects Diabetic Mouse Hearts by Targeting the mTOR/HIF-1α PathwayPreprint
Sun, P., Ding, Y., Luo, J., Zhong, J., & Xie, W. (2020) · doi:10.21203/rs.3.rs-123774/v1
Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-Foxo1 signaling pathwayPreprint
Wang, J., Bai, J., Duan, P., Wang, H., Li, Y., & Zhu, Q. (2020) · doi:10.21203/rs.3.rs-33214/v1
At the heart of the matter
de Wit‐Verheggen, V. H. W. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220601vw
Bone marrow-derived stem cells:characters, potentials, and applicationsin the treatments of diabetic complications
Nguyen, N. H., Nguyen, C. T., Nguyen, C. T., Nguyen, V. H., Ngo, T. M. T., & Lam, P. P. H. (2022) · Ministry of Science and Technology Vietnam · doi:10.31276/vjst.64(7).28-33
Metformin Regulates Autophagy to Attenuate Mitochondrial Dysfunction in High Glucose-stimulated H9C2 Cardiomyocytes via the AMPKα/Sirt1/Parkin Signaling AxisPreprint
Zhang, Z., Ling, Y., Huang, Z., Zhong, J., Chen, Q., Liu, J., Tang, X., & Peng, L. (2022) · Research Square · doi:10.21203/rs.3.rs-2281485/v1
Duodenal-jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve oxidative stress diabetic cardiomyopathyPreprint
yang, G., Zhao, X., Liu, Z., Ge, Z., Yao, L., Cheng, Z., Wang, X., Zhang, X., & Wang, K. (2023) · Research Square · doi:10.21203/rs.3.rs-2452774/v1
The Targeted Role of SGLT2 Inhibitors in Patients with Diabetic Cardiomyopathy
Chatterjee, S., & Patra, S. (2023) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-12082
Analysis of the possibility of effectiveness that therapeutic techniques for diabetes in the treatment of heart failure
Huang, Q. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/6/20230221
Electrical Remodeling and Arrhythmogenicity of Ventricular Myocardium in Streptozotocin-Induced Diabetes Mellitus
Sedyakina, E., Gonotkov, M., Tsvetkova, A., Azarov, J. E., & Ovechkin, A. O. (2023) · IEEE Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB) · doi:10.1109/csgb60362.2023.10329863
Visualizing the Role of ER Stress in Diabetic Cardiomyopathy: A Bibliometric AnalysisPreprint
Ji, Y., Jin, Z., xu, Z., Zhou, L., Wen, X., Gao, L., Su, W., Xia, Z., Xia, Z., & Lei, S. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4641193
Analyzing Short and Medium-Term Morbidity and Mortality in Patients with Heart Failure and Borderline Ejection Fraction (EF: 40-49%).
BENCHEBOUB, I. B., Bendiab, N. T., Ghalmi, A., Cherifi, Y. M. S., & Benkhedda, S. (2024) · Clinical Medicine And Health Research Journal · doi:10.18535/cmhrj.v4i1.296
Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Myocardial Injury in Type 2 Diabetic Rats by Regulating Autophagy
Liu, Y., Ma, L., Xu, W., La, X., Zhang, B., Jianmei, C., Tian, C., Chang, H., & Li, J. (2024) · Pharmacognosy Magazine · doi:10.1177/09731296231220433
Signaling pathway and pharmacology
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00005-6
Propolis extract supplementation in the complementary treatment of adults and elderly with Type 2 Diabetes Mellitus: a systematic review of clinical trial
Santos, Y. S. D., Borda, L. L., Casaes, R. S., Pereira, A. D. S., Lima, E. C. D. S., & Cardoso, F. D. S. (2024) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv22n1-094
Research Progress on the Relationship between HbA1c and Diabetes Complicated with Chronic Heart Failure
迪达尔, ·. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141161
Antiapoptotic Effect of Target Protein for Xklp2 on Diabetic Rat Cardiomyocytes
Zhang, Y., Li, L., Wang, W., Li, M., Cao, A., & Hu, Y. (2024) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2024.3832
Targeting Insulin- and Calcium-related Pathways for Potential Treatments for Alzheimer's Disease and Diabetes
Sood, S., Devi, S., Singh, T. G., & Singh, R. (2024) · Current Signal Transduction Therapy · doi:10.2174/0115743624299306240419054021
Heart to Predict
Harms, P. P. (2024) · doi:10.5463/thesis.663
Effect of SGLT-2 Inhibitors on Zebrafish Model with Diabetic Heart Failure
-, S. Y. W., Wankhade, A. M., Vyas, J. V., & Paithankar, V. (2024) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2024.v06i03.22693
Fetal Strain and Strain Rate Measured with Speckle Tracking Echocardiography in Maternal Diabetes: Systematic Review
de Vet, C. M., Zamani, H., van der Woude, D. A. A., Clur, S. B., Oei, S. G., van Laar, J. O. E. H., & van Oostrum, N. H. M. (2024) · Fetal Diagnosis and Therapy · doi:10.1159/000538413
Diabetes and mitochondrial transplantation
Louwagie, E. J., & Baack, M. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18858-9.00022-6
SGLT2 Inhibitors and Mechanism of Cardiovascular Benefits in Type 2 Diabetes
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7568-2_2
REPOLARIZATION DISPERSION AS A PREDICTOR FOR LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IN SHORT-TERM EXPERIMENTAL DIABETES MELLITUS
Sedyakina, E. N., Tsvetkova, A., Durkina, A., Gonotkov, M., Эрнестович, А. Я., & Ovechkin, A. O. (2024) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2024-4-133-143
Effect of high glucose on the gene expression profiling in cardiac fibroblasts from rats at different ages
Mo, Q., Zhan, A., Bai, R., Lin, S., Feng, J., Li, T., Lao, Z., Yang, X. Q., Wang, K., Rong, X., et al. (2025) · PeerJ · doi:10.7717/peerj.19040
Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotypePreprint
Iveljić, I., Young, M., Corhodzic, E., Cullen, F., Prag, H. A., Murphy, M. P., & Aksentijević, D. (2025) · medRxiv · doi:10.1101/2025.04.14.25325801
Protective effects of aerobic exercise on cardiac histology and stereological parameters in a rat model of type 2 diabetes mellitus
Rashidpour, A., Piralaiy, E., Hamidian, G., & Ismael, B. R. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01641-5
Risk of Ischaemic and Non‐Ischaemic Heart Failure in People With Type 2 Diabetes: Observational Study in 1.6 Million People in England
Panchal, K., Lawson, C. A., Shabnam, S., Khunti, K. K., & Zaccardi, F. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70072
Growth Factor Receptor‐Binding Protein 10 Promotes High Glucose‐Induced H9c2 Cardiomyoblast Apoptosis via Inhibition of the ERK1/2 and JAK2/STAT3 Signaling Pathways
Wang, Y., Bu, F., Zhang, M., Zhang, Y., Hu, Y., & Liu, L. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70081
Mortality Trends Related to Diabetes Mellitus and Heart Failure: A Retrospective Study
Prushni, B., Dhillon, H., Patel, D., Lu, X., Pulluru, M., & Edwards, J. (2025) · Cureus · doi:10.7759/cureus.90376
Unlocking the Diagnostic and Therapeutic Potential of microRNA in Diabetes: A Bibliometric and Visualized Analysis (2003–2023)
Yu, J., Xia, K., Feng, J., Xu, Z., Zhang, Z., Xiao, G., Zhu, H., Xue, W., Chen, F., & Xie, X. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s533519 · Cited by 1
Deciphering the structural attributes of PPAR-γ and SIRT1 to identify their dual activators using a combined molecular modeling approach
Dogra, S., Bhattacharya, A., Narendra, G., Gautam, S., & Silakari, O. (2025) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2025.141104
Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy
Zhao, T., & Sun, N.-Z. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i12.114485
Additional file 1 of BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21
Zheng, H., Zhang, X., Li, C., Wang, D., Shen, Y., Lu, J., Zhao, L., Li, X., & Gao, H. (2024) · Figshare · doi:10.6084/m9.figshare.26827386
Additional file 1 of The joint association of diabetes status and NT-ProBNP with adverse cardiac outcomes in patients with non-ST-segment elevation acute coronary syndrome: a prospective cohort study
Wang, M., Su, W., Chen, H., & Li, H. (2023) · Figshare · doi:10.6084/m9.figshare.22620292
Additional file 1 of Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy
Liu, B., Wei, Y., He, J., Feng, B., Chen, Y., Guo, R., Griffin, M. D., Hynes, S. O., Shen, S., Liu, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25687364
Additional file 1 of The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
Puig-Jové, C., Julve, J., Castelblanco, E., Julián, M. T., Amigó, N., Andersen, H. U., Ahluwalia, T. S., Rossing, P., Mauricio, D., Jensen, M. T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21628735
Additional file 1 of Dynamic evolution and mechanism of myocardial glucose metabolism in different functional phenotypes of diabetic cardiomyopathy — a study based on 18 F-FDG microPET myocardial metabolic imaging
Shao, X., Liu, Y., Zhou, M., Xu, M., Chen, Y., Huang, H., Lin, J., & Wang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26579753
Additional file 1 of Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial
Gohari, S., Reshadmanesh, T., Khodabandehloo, H., Fathi, M., Ahangar, H., Arsang-Jang, S., Ismail‐Beigi, F., Ghanbari, S., Dadashi, M., Muhammadi, M. J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14889781
Additional file 6 of Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2
Jin, L., Zhang, J., Deng, Z., Liu, J., Han, W., Chen, G., Si, Y., & Ye, P. (2020) · Figshare · doi:10.6084/m9.figshare.11998845
Additional file 1 of Cardioprotective effects of polydatin against myocardial injury in diabetic rats via inhibition of NADPH oxidase and NF-κB activities
Tan, Y.-Y., Chen, L.-X., Fang, L., & Zhang, Q. (2020) · Figshare · doi:10.6084/m9.figshare.13467663
Additional file 2 of GSTM2 alleviates heart failure by inhibiting DNA damage in cardiomyocytes
Xu, H., Wang, Z., Wang, Y., Pan, S., Zhao, W., Chen, M., Chen, X., Tao, T., Ma, L., Ni, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26647626
Additional file 1 of GSTM2 alleviates heart failure by inhibiting DNA damage in cardiomyocytes
Xu, H., Wang, Z., Wang, Y., Pan, S., Zhao, W., Chen, M., Chen, X., Tao, T., Ma, L., Ni, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26647623
Additional file 1 of Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
Yu, M., Sun, Y., Shan, X., Yang, F., Chu, G., Chen, Q., Han, L., Guo, Z., & Wang, G. (2022) · Figshare · doi:10.6084/m9.figshare.21300856
Cardiac-restricted Nrf2 activation blocks diabetic cardiomyopathy via Akt-driven glycolysis and AMPK-PGC-1α fatty-acid oxidation
Jiang, Y., 陶大云, Jin, Z., Li, Z., He, X., Zhou, H., Zhu, H., & Ren, L. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02660-1 · Cited by 1
Barriers to Physical Activity in Patients with Diabetic Cardiomyopathy: A Qualitative Study on Perceived Risks and Motivational ChallengesPreprint
Gu, L., Zhou, M., Liang, D., Xiaoyong, W., & Zhang, K. (2026) · Research Square · doi:10.21203/rs.3.rs-8696663/v1
Therapeutic Ultrasound in Cardiovascular Medicine: Applications of Low-intensity Pulsed Ultrasound and Ultrasound-targeted Microbubble Destruction
Shi, Y., Ye, Y., Chang, S., Lu, D., & Chu, Y. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07864-9
Risk factors associated with cardiac dysfunction in men with erectile dysfunction
Durukan, E., Jensen, C. F. S., Dons, D. M., Sengeløv, M., Landler, N. E., Skaarup, K. G., Lassen, M. C. H., Johansen, N. D., Østergren, P. B., Sønksen, J., et al. (2026) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdag074
The N6-Methyladenosine RNA Demethylase AlkB Homolog 5 (ALKBH5) in Metabolic Diseases: Molecular Mechanisms and Pharmacological Implications—A Review
Cai, G., Fu, L., Zhang, X., & Yan, M. (2026) · Biomolecules · doi:10.3390/biom16040499
Panax notoginseng flower protects against diabetic cardiomyopathy by regulating the ACSL4/ALOX15 pathway
Zhou, Y., Ouyang, L., Dong, L., Zhang, X., Du, J., Sun, S., Ussher, J. R., Chan, J. S. F., Chen, L., Huang, D., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1780442
Dépôts de graisse ectopique : étude de leur développement et de leur modulation
Abdesselam, I. (2016) · theses.fr (ABES) · doi:10.70675/1f016024z175cz4b35z8034za3b418cfe9c3
Coeur, mitochondries, lésions d'ischémie-reperfusion : impact du diabète et du post-conditionnement par les ligands opiacés
Richer, R. (2018) · theses.fr (ABES) · doi:10.70675/4872f281z6a43z4c94z9905z0d548007c0ac
Rôles et mécanismes d’action de la protéine Epac1 mitochondriale dans les pathologies cardiaques
Laudette, M. (2019) · theses.fr (ABES) · doi:10.70675/5a24dee4ze02cz4524za612zea3224b1ea32
Du prédiabète au diabète de type 2 : quels impacts sur la santé cardiovasculaire dans le sexe féminin ? : approche thérapeutique par le Resvératrol contre les lésions myocardiques liées à l’ischémie-reperfusion dans le diabète de type 2
Fourny, N. (2019) · theses.fr (ABES) · doi:10.70675/846aa6e5z8362z45a5z8e8dz2452913634b4
Role of Epac2 in high glucose-mediated cardiac calcium mishandling.
Hayek, M. S. E. (2020) · theses.fr (ABES) · doi:10.70675/c2d7d63fzf026z4bbbz9358z403c1386e2c7
Homéostasie calcique mitochondriale dans le contrôle des troubles du rythme associés à la cardiomyopathie métabolique
Fossier, L. (2021) · theses.fr (ABES) · doi:10.70675/36de6f26zc009z49d6zaa35za5cfbe95b345
Diabète et insuffisance cardiaque : approche épidémiologique par l’analyse croisée de différentes sources de données de santé
Wargny, M. (2022) · doi:10.70675/5d8d8ab5z24f5z4395zbcdfz1c90d9ca526d
Genetic Basis of Cardiomyopathies Associated with Endocrinopathies: A Comprehensive Review
Concistrè, A., Caramazza, C., D’Abbondanza, M., Santori, R., & Imperoli, G. (2026) · Cardiogenetics · doi:10.3390/cardiogenetics16020008
Negotiating energy, fear, and control: a qualitative study of nutrition and exercise experiences among middle-aged adults with obesity and diabetes-related cardiomyopathy
Wang, L., Gu, L., Wan, X., & Zhang, K. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03320-7
Revisiting Glycemic Control Targets: Survival Outcomes by Glycated Hemoglobin Levels Among Patients With Diabetes Under Contemporary Antidiabetic Therapy
Lin, D. S., Lo, H.-Y., & Lee, J.-K. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.046125
Hyperglycemia-driven metabolic memory signaling destabilizes METTL1 to trigger inflammatory hypertrophy and fibrosis in diabetic cardiomyopathy
Yuan, Y., Zhang, A., Jiang, Y., Tao, D., Guo, Z., Zhu, H., Zeng, Y., & Shi, H. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02699-0
Evaluation of the therapeutic effect of new hypoglycemic drugs on patients with heart failure with reduced ejection fraction and type 2 diabetes: a systematic review and network meta-analysis
Chen, X.-R., Mao, X.-P., Luo, D., Chang-qing, Y., & Bai, J.-N. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1799254
Calcium Signaling Dysregulation in Diabetic Cardiomyopathy: Roles of STIM and Orai Channels
Smani, T., Dominguez-Liste, B., Gutiérrez-Barranco, M. D. J., Aspron, C., Cordero-Sánchez, C., Calderón-Sánchez, E., Rosado, J. A., & Hmadcha, A. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_797
The Calmodulin/Striatin Interaction Is Enhanced in Diabetic Hearts and Defines Novel Signaling Clusters Implicated in Cardiac Remodeling
Chacar, S., Hageh, C. A., Ali, L., Zalloua, P., Suleiman, M. S., Howarth, F. C., Khraibi, A. A., & Nader, M. (2026) · ACS Omega · doi:10.1021/acsomega.5c13122
Effects of Adiponectin on Akt Expression Under Hypoglycemic and Hyperglycemic Conditions in HL-1 Cardiomyocytes
Papur, Ö. Ş. (2026) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.1931214
Preventive Antiarrhythmic Properties of Melatonin in Experimental Diabetic Cardiomyopathy in Rats
Ovechkin, A. O., Gonotkov, M., Abramochkina, A. S., Sedyakina, E., Durkina, A., Bernikova, O. G., Velegzhaninov, I. O., & Azarov, J. E. (2026) · Journal of Pineal Research · doi:10.1111/jpi.70153
Decoding the secretory blueprint of bone healing: from gradients to regeneration
Yang, W., Wang, Y., Liu, K., Zhao, Y., & Wang, W. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1873387
Effects of Ilex aquifolium Polyphenols on Cardiovascular, Renal and Liver Structure in a Rat Model of Metabolic Syndrome: A Biochemical and Histological Study
Nowaczyk, R., Kuropka, P., Szumny, A. J., Pachura, N., Zwyrzykowska-Wodzińska, A., Pogoda-Sewerniak, K., & Kupczyński, R. (2026) · Molecules · doi:10.3390/molecules31142487
Hypercaloric Diet Induces Cardiovascular Dysfunction Through Altered Purinergic Signaling on Atrial and Vascular Contractility
Musial, D. C., Jurkiewicz, A., Jurkiewicz, N. H., & Bomfim, G. H. S. (2026) · Biology · doi:10.3390/biology15141166
Metabolic regulation and diabetic cardiomyopathy
Du, H., & Chen, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34186-1.00019-0
Epicardial Adipose Tissue in Diabetic Heart Disease: Impact on Cardiac Function and Modulation Strategies, a Comprehensive Review
Đuzel, A., Rotkvić, P. G., Babić, Z., Šipoš, I. H., Bekić, M., Bratičević, M. N., Rotkvić, L., & Berković, M. C. (2026) · Medicina · doi:10.3390/medicina62071402
A Web-Based Clinical Decision Support System for Cardio-Kidney Risk Stratification in Critically Ill Patients with Diabetic Kidney Disease: Development, SHAP Interpretability, and Multi-Center External ValidationPreprint
Yu, Z., Zhang, B., Zeng, L., Liu, L., Chen, L., Wang, J., & Du, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10139860/v1
Urokinase-type plasminogen activator, WNT signaling, and brain natriuretic peptide in heart failure patients with end-stage kidney disease
Salim, R. F., Alfatlawi, W. R., & Aldabagh, M. A. H. (2026) · AIP conference proceedings · doi:10.1063/5.0329992
Human cellular metabolomics
Chu, B., Li, X., & Gouda, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44091-5.00006-6
Cardiomyocyte OTUD7b drives diabetic cardiomyopathy via deubiquitinating and stabilizing TAK1
Han, X., Liu, G.-X., Zheng, J.-N., He, M.-Y., Zhuang, L., Zhang, J.-J., Tong, J., Huang, Z.-Q., Wu, Y., Zhou, T.-Q., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01891-w
Diabète et cœur : comprendre la glucotoxicité cardiaque
Prieur, X., & Joubert, M. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.07.005
Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis
Tang, B., Yu, Y., Tang, Y., Yu, R., & Liu, X. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-121200
TRIM47, stabilized by YTHDF3-mediated m6A modification, promotes cardiac lipid accumulation and aggravates diabetic cardiomyopathy
WANG, W., Xie, L., 陈桂兰, Zuo, X., Zhong, M., YANG, T., & Wu, W. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102437
Cardioprotective Effects of Dorzagliatin Against Streptozotocin-induced Diabetic Cardiomyopathy: Involvement of Anti-hyperlipidemic, Antioxidant, and Anti-inflammatory Mechanisms
Liu, F., Du, W., Wang, Y., Zhang, G., Ji, Q., & Zhang, M. (2026) · Pharmacognosy Magazine · doi:10.1177/09731296261487039
Diabetic cardiomyopathy as a disorder of proteostatic maladaptation: context-dependent ubiquitin-specific protease networks
Meng, X., Guo, S., Lin, H., Li, R., Peng, W., Sun, L., Shi, X., & Yang, L. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1910665
Multi-omics profiling reveals coordinated metabolic and immuno-inflammatory remodeling in a high-fat diet and single-dose streptozotocin-induced mouse model of diabetic cardiomyopathy
Zhang, F., Ai, C., Zhang, H., Sun, X., Wang, L., Li, C., Cai, W. L., Yin, X., 王妍心, Li, Y., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06682-z
Efficacy and safety of esaxerenone versus angiotensin II receptor blockers in older patients with hypertension, with and without type 2 diabetes mellitus: a predefined subgroup analysis of the ESCORT-HT study
Ohishi, M., Kario, K., Ohbayashi, H., Ishii, H., Kato, M., Nozaki, M., Abiru, N., Fukui, T., Nomura, K., Fukushima, Y., et al. (2026) · Hypertension Research · doi:10.1038/s41440-026-02779-2

Authors: Bugger, H., & Abel, E. D.
Affiliations: University of Freiburg (DE)
University of Iowa (US)
Corresponding author: Abel, E. Dale
ORCID: Bugger, Heiko
Abel, E. Dale
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2014-01-30
Volume: 57
Issue: 4
Pages: 660-671
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-014-3171-6
PMC: PMC3969857
OpenAlex: W2006499762
Cited by: 903
References: 153
Citations by year: 2026: 51 · 2025: 76 · 2024: 75 · 2023: 79 · 2022: 95 · 2021: 103 · 2020: 100 · 2019: 66 · 2018: 84 · 2017: 62 · 2016: 54 · 2015: 43 · 2014: 14
FWCI: 9.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL108379, U01HL087947)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092065)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: diabetic cardiomyopathy, diabetes mellitus, heart failure, myocardial structure and function, type 1 diabetes, type 2 diabetes, animal models of diabetes, genetically engineered mouse models, cardiovascular complications of diabetes
MeSH terms: Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Humans, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of diabetic cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks